Enzyme derepression and feedback inhibition of the first enzyme are the regulatory mechanisms demonstrated for the tryptophan pathway in Saccharomyces cerevisiae. The relative contributions of the two mechanisms to the control of the flux through the pathway in vivo were analyzed by (i) measuring feedback inhibition of anthranilate synthase in vivo, (ii) determining the effect of regulatory mutations on the level of the tryptophan pool and the flux through the pathway, and (iii) varying the gene dose of individual enzymes of the pathway at the tetraploid level. We conclude that the flux through the pathway is adjusted to the rate of protein synthesis by means of feedback inhibition of the first enzyme by the end product, tryptophan. The synthesis of the tryptophan enzymes could not be repressed below a basal level by tryptophan supplementation of the media. The enzymes are present in excess. Increasing or lowering the concentration of individual enzymes had no noticeable influence on the overall flux to tryptophan. The uninhibited capacity of the pathway could be observed both upon relieving feedback inhibition by tryptophan limitation and in feedback-insensitive mutants. It exceeded the rate of consumption of the amino acid on minimal medium by a factor of three. Tryptophan limitation caused derepression of four of the five tryptophan enzymes and, as a consequence, led to a further increase in the capacity of the pathway. However, because of the large reserve capacity of the "repressed" pathway, tryptophan limitation could not be imposed on wild-type cells without resorting to the use of analogs. Our results, therefore, suggest that derepression does not serve as an instrument for the specific regulation of the flux through the tryptophan pathway.
Enzyme derepression and feedback inhibition of the first enzyme are the regulatory mechanisms demonstrated for the tryptophan pathway in Saccharomyces cerevisiae. The relative contributions of the two mechanisms to the control of the flux through the pathway in vivo were analyzed by (i) measuring feedback inhibition of anthranilate synthase in vivo, (ii) determining the effect of regulatory mutations on the level of the tryptophan pool and the flux through the pathway, and (iii) varying the gene dose of individual enzymes of the pathway at the tetraploid level. We conclude that the flux through the pathway is adjusted to the rate of protein synthesis by means of feedback inhibition of the first enzyme by the end product, tryptophan. The synthesis of the tryptophan enzymes could not be repressed below a basal level by tryptophan supplementation of the media. The enzymes are present in excess. Increasing or lowering the concentration of individual enzymes had no noticeable influence on the overall flux to tryptophan. The uninhibited capacity of the pathway could be observed both upon relieving feedback inhibition by tryptophan limitation and in feedback-insensitive mutants. It exceeded the rate of consumption of the amino acid on minimal medium by a factor of three. Tryptophan limitation caused derepression of four of the five tryptophan enzymes and, as a consequence, led to a further increase in the capacity of the pathway. However, because of the large reserve capacity of the "repressed" pathway, tryptophan limitation could not be imposed on wild-type cells without resorting to the use of analogs. Our results, therefore, suggest that derepression does not serve as an instrument for the specific regulation of the flux through the tryptophan pathway.
Although tryptophan is synthesized along the same pathway in all microorganisms studied so far, there are considerable differences in the enzymatic organization of the pathway as well as in the regulatory mechanisms used by different organisms to control the level of the end product, tryptophan.
In Saccharomyces cerevisiae, the genes coding for the five enzymes of the pathway (Fig. 1 ) are all unlinked and mostly located on different chromosomes. Products of the two genes, trp2 and trp3, form an aggregate which catalyzes the first and fourth steps of the pathway (23) . Tryptophan synthase, which catalyzes the last step of the pathway, is coded for by a single gene (6) , but it is possible to obtain mutants that eithersynthase, the first enzyme of the pathway, by tryptophan. The significance of this mechanism in vivo was confirmed by the isolation of mutants with a feedback-insensitive anthranilate synthase, which overproduce tryptophan and excrete the amino acid into the medium (7, 22) . In contrast to earlier reports (5, 17) , Fantes et al. (7) found no repression of the enzymes of the pathway by tryptophan. A two-to threefold derepression of the tryptophan enzymes can, however, be generated by growth of wild-type cells in the presence of the analogs 5-methyltryptophan or indole acrylic acid (7, 21a, 22) . These analogs were shown to cause tryptophan limitation by inhibiting a specific step in the synthesis of the amino acid (21a) .
The tryptophan pool in S. cerevisiae, as reported by Fantes et al. (7) and Weiss et al. (27) , is extremely small for cells growing exponentially in minimal medium. This suggests that the flux through the pathway must be rigorously controlled and poses the question of how this control is exerted. The present report is an effort [t~~.
inhibition and derepression in controlling the flux through the pathway in vivo. By using completely or partially blocked mutants, by varying the gene dose for individual enzymes, and by adding intermediates or analogs to the growth medium, we generated specific changes in the flux through the pathway and measured the regulatory response of the cell. Further information was obtained from the characterization of the regulatory mutants and their effects on the flux through the pathway in vivo.
MATERIALS AND METHODS Organisms. All the strains were derived by mutation and recombination from the isogenic wild-type strains of S. cerevisiae X2180-1A (mating type a) and X2180-1B (mating type a). The wild-type strains were obtained from T. Manney, Manhattan, Kan. The main characteristics of the strains used are presented in Table 1 .
Most of the strains have been described previously (7, 21a, 22 Recombinants between various mutants were constructed either by the "spore en masse" technique or by tetrad analysis as described before (22) Enzyme assays. All enzyme assays were performed at 37°C with Triton X-100-treated cell suspensions (21a) .
Protein content of the detergent-treated cell suspensions was measured by the method of Herbert et al. (12) . Bovine serum albumin (Calbiochem, La Jolla, VOL. 134, 1978 M). Determination of the tryptophan pool. The size of the tryptophan pool was determined in exponentially growing cultures with the microbiological assay using Lactobacillusplantarum as described by Fantes et al. (7) .
Construction of tetraploid gene dosage series. Tetraploid gene dosage series were constructed essentially as described by Hilger (13) , except that the "spore en masse" technique was employed instead of tetrad analysis. All strains used for the construction of tetraploid gene dosage series had a low reversion rate (-10-') and showed no residual growth in the absence of tryptophan (see Table 1 ).
Chemicals. reference 7). Moreover, the basal levels of the tryptophan enzymes provided the capacity for supporting considerably higher growth rates than those observed in minimal medium. In a wild-type culture growing in minimal medium supplemented with Casamino Acids, all the amino acids with the exception of tryptophan were provided in the medium. This resulted in a 40% increase in growth rate. Not only did tryptophan not become growth limiting under these conditions, the culture also failed to respond to the increased rate of tryptophan consumption by an increase in the enzyme levels. In a previous publication, we reported the isolation of a class of 5-methyltryptophan-sensitive mutants that have lost the ability to derepress their tryptophan enzymes under the influence of the analog (22) . As shown in Table 3 for strain RH 375, these mutants showed the same enzyme levels as the wild-type strain on MV medium. However, they failed to increase their enzyme levels in the presence of 5-methyltryptophan and were therefore severely inhibited in growth (>65% at 10-4 M 5-methyltryptophan). Starting (14, 20, 25) .
Control of enzyme activity. Feedback inhibition of anthranilate synthase, the first enzyme of the pathway, by tryptophan has been demonstrated repeatedly in vitro (5, 16, 22) . Figure 2A illustrates (Fig. 2B) . As soon as the availability of tryptophan became growth limiting, however, as evidenced by a reduction in growth rate, the cells started to accumulate large amounts of anthranilate. Identical results were obtained when comparable concentrations of L-tryptophan or DL-tryptophan were used instead of indole (data not shown). It thus appears that tryptophan accumulated within the cell, whether exogenously supplied as tryptophan or endogenously derived from indole, acts to prevent any further flux through the pathway by inhibiting the activity of anthranilate synthase. This conclusion is confirmed by the experiment presented in Fig.   2C , where anthranilate accumulation in a tryptophan-starved culture of strain RH 21 was shown to stop immediately when indole (or tryptophan) was added to the growth medium. Anthranilate accumulated at the time of indole addition was very stable, and no reduction in fluorescence was observed after 8 h of incubation at 30°C. In contrast to this, the recombinant strain RH 21 511, which carries a feedback-insensitive anthranilate synthase, continued to accumulate anthranilate even in the presence of high concentrations of indole (Fig. 2D) .
From the amount ofanthranilate accumulated in a given time interval, it is possible to approximate the rate of anthranilate accumulation of a culture and, hence, the in vivo activity of anthranilate synthase (see Materials and Methods). The steady-state rates of anthranilate accumulation in recombinants of the anthranilate phosphoribosyltransferase-negative strain RH 21 with various regulatory mutants are summarized in Table 4 . In the presence of tryptophan or indole in the growth medium, only strains with a feedback-insensitive anthranilate synthase accumulated anthranilate. In these strains, the rate of accumulation in the presence of tryptophan equaled about 65 to 70% of the uninhibited rate in the absence of the tryptophan and was somewhat smaller than the residual activity of 80% observed in vitro ( Fig. 2A) Tryptophan starvation of an auxotroph did not lead to reproducible derepression of the enzyme levels, since growth and protein synthesis stopped soon after the removal of the amino acid. Strains with leaky mutations, however, continued to grow in the absence of the amino acid, allowing protein synthesis to proceed and derepression ofthe enzymes to take place. Strain RH 570 is a revertant of strain RH 21 that carries an external suppressor mutation of unknown nature and grows with 25% of the wildtype rate in the absence of typtophan. As was done with strain RH 21, we recombined strain RH 570 with various regulatory mutations and measured the rate of anthranilate accumulation in these strains after removing tryptophan from the growth medium (Fig. 3) . Whereas the rate of accumulation reached a plateau 60 to 90 min after removal of the amino acid for the regulatory mutants RH 570-558 and RH 570-375, it continued to increase over a period of at least 8 h for strain RH 570-511. This increase is generated by the process of derepression and presumably is a direct reflection ofthe increased activity of anthranilate synthase.
Influence of derepression and feedback inhibition on the endogenous tryptophan pool. Although measurements of the in vivo activity of anthranilate synthase in auxotrophs under conditions of tryptophan excess or tryptophan limitation may give an idea as to how the regulatory mechanisms of derepression and feedback inhibition function under extreme conditions, they do not tell to what extent these mechanisms contribute to the control of the flux through the pathway under normal conditions. Measurements of the tryptophan pool in mutants with altered feedback sensitivity of anthranilate synthase or with constitutively derepressed enzyme levels may provide an answer to this question, although the interpretation ofpool data is complicated by the fact that the amino acid may be rapidly degraded or extensively compartmentalized within the cell.
As reported previously by Fantes et al. (7) and illustrated in Table 5 , the tryptophan pool in a wild-type strain of S. cerevisiae is extremely small. In contrast to this, strains with a feedback-insensitive anthranilate synthase showed a 40-fold increase in pool level and, in addition, excreted large amounts of tryptophan into the growth medium. While the pool level was essentially the same for both strains RH 511 and RH 511-558, the latter strain excreted considerably more tryptophan into the growth medium, reflecting its elevated enzyme levels. On the other hand, strain RH 558 showed a mere twofold increase in the level of the tryptophan pool and excreted no tryptophan into the medium despite its constitutively derepressed enzyme levels. It thus appears that the tryptophan pool level is rigorously controlled in strains with intact feedback sensitivity of anthranilate synthase, while the amino acid is overproduced when the feedback mechanism does not operate. From the rates of tryptophan accumulation given in 2 pg of L-tryptophan per ml, and accumulation of anthranilate was followed. One hour after the onset of tryptophan limitation (reflected by a reduction in growth rate, data not shown), the culture was divided, and indole (50 pg/ml, final concentration) was added to a portion of the culture (arrow). Symbols: 0, unsupplemented control culture; A, culture plus indole (50 ig/ml).
VOL. 134, 1978 pathway was determined as a measure for the state of derepression of the individual cultures. Growth rates and enzyme activities of the gene dosage series are given in Table 6 . We found that the reduction in gene dose and enzyme activity was strictly proportional for all enzymes of the pathway. The gene dose for the individual enzymes could be reduced by 75% without effect on the growth rate or the activity of the control enzymes. The only exception was anthranilate phosphoribosyltransferase (trp4) at the lowest gene dose: whereas the gene dose for this enzyme could be reduced by 50% without any consequence, a further reduction led to growth inhibition and caused derepression ofthe control enzymes anthranilate synthase and indoleglycerolphosphate synthase (Table 6 , strain RH 21). That these effects are actually caused by tryptophan limitation was confirmed by the result that both growth inhibition and enzyme derepression were reversed by addition of tryptophan to the growth medium (Table 7 ). In addition, the tetraploid strain with 1/4 of the anthranilate phosphoribosyltransferase gene dose accumulated anthranilate when growing in MV medium, as would be expected for a strain with growth-limiting levels of anthranilate phosphoribosyltransferase; the rates of anthranilate accumulation suggest a complete release of feedback inhibition of anthranilate synthase and are virtually identical to the in vitro activity of anthranilate synthase measured in cells grown un- 
DISCUSSION
The role of feedback inhibition of anthranilate synthase. With 0.07 nmol/mg dry weight, the tryptophan pool of the wild-type strain X2180-1A of S. cerevisiae (7) is considerably smaller than the published values for other amino acids in yeast (4, 8) and more than 10 times smaller than the tryptophan pool in Neurospora crassa (21) . Because of its small size, the buffering capacity of the tryptophan pool can be only very limited, and one could expect that even a small reduction in the flux through the pathway should result in tryptophan limitation. As shown by the analysis of growth and enzyme activities in a tetraploid gene dosage series of all five tryptophan enzymes, none of the enzymes of the pathway is synthesized in limiting amounts. With one exception, which will be discussed below, gene dose and enzyme activities could be reduced by as much as 75% without any effect on growth rate or on the activities of the other enzymes of the pathway. That at least the last four enzymes of the pathway are produced in excess is also evident from the fact that mutants with a feedback-insensitive anthranilate synthase showed a 40-fold increase in the tryptophan pool level and, in addition, excreted the amino acid into the medium. The breakdown of regulation of the tryptophan pool in these mutants suggests that feedback inhibition of anthranilate synthase plays a central role in the control of the flux through the pathway.
This conclusion was corroborated by measuring the rate of anthranilate accumulation in mutants lacking anthranilate phosphoribosyltransferase activity, both in the presence and in the absence of tryptophan. The amino acid, whether introduced exogenously as tryptophan or synthesized endogenously from indole, caused a complete inhibition of anthranilate synthase, while removal of tryptophan from the growth medium led to the accumulation of large amounts of anthranilate. The rates of anthranilate accumulation in strains carrying various regulatory mutations were virtually identical to the corresponding levels of anthranilate synthase activity determined in vitro and reflect the state of derepression of the cultures. For maximally derepressed cultures, they reached values about 10 times higher than the 0.3 nmol of tryptophan per mg of protein per min (7) needed in the wild-type strain to maintain the growth rate of 0.3 in MV medium. The great majority of tryptophan is probably used for protein synthesis, since the amount needed for nicotinic acid biosynthesis is very small, and the degradative enzymes presumably need to be induced by growth in the presence of exogenous trypto-57 VOL. 134, 1978 on December 15, 2017 by guest http://jb.asm.org/ phan (10, 11); or, alternatively, their affinity constants for tryptophan may require high internal concentrations of the amino acid. From the uninhibited rate of anthranilate accumulation by anthranilate synthase in vivo, about 1.5 nmol/mg of protein per min, and the calculated flux through the pathway of 0.31 nmol/mg of protein per min, it follows that the tryptophan pool inhibits the activity of anthranilate synthase by about 75 to 80% in a wild-type culture growing in minimal MV medium. This agrees well with the estimation of Fantes et al. (7) based on in vitro data only.
While the feedback-insensitive strain RH 511 and its constitutively derepressed derivative RH 511-558 accumulated tryptophan at 170 and 710 times the wild-type rate, respectively, the constitutively derepressed strain RH 558 did not accumulate the amino acid in significantly higher amounts than the wild-type strain itself (Table 5 ). This means that derepression of the enzymes of the pathway does not lead to an increase of the flux; quite to the contrary, the net flux through the pathway in strain RH 558 was reduced to 0.23 nmol/mg of protein per min because of the slower growth rate of this mutant strain (Ju = 0.22 in MV medium). Thus, while derepression clearly affects the maximal capacity of both anthranilate synthase and the tryptophan pathway as a whole, this increased potential is expressed only under conditions where feedback inhibition of anthranilate synthase does not operate, such as during tryptophan limitation or in feedback-insensitive mutants.
Both an increase in anthranilate synthase concentration in derepressed cells and a reduction of it by decreasing the gene dose of the enzyme remained without effect on the flux through the pathway. Since the activities of the enzyme in derepressed cells (4.6 nmol/mg of protein per min) and in the tetraploid strain with the smallest gene dose (0.36 nmol/mg of protein per min for tip3C) differed by more than 10-fold, it is evident that the net flux through the pathway is independent from the absolute amount of enzyme present.
The flux through the pathway is adjusted to the growth rate by feedback inhibition of anthranilate synthase only. The feedback inhibition constant (KJ) of the enzyme and the growth rate also determine the size of the tryptophan pool.
Control of enzyme synthesis. As shown previously by Fantes et al. (7) , the tryptophan enzymes are not regulated in response to the level of the tryptophan pool; neither increased pool levels in the presence of exogenously supplied tryptophan or indole, or as a result of a feedback-insensitive anthranilate synthase, nor reduced pool levels in mutants with increased feedback sensitivity of anthranilate synthase affect the activity of the tryptophan enzymes. In this study we have shown that the activity of all tryptophan enzymes is proportional to their gene dose, indicating that they are transcribed and translated constitutively. In addition, the enzymes of the pathway are synthesized in at least a threefold excess during growth on minimal medium. A slight deviation from the strict proportionality was observed for anthranilate synthase in the trp2 gene dosage series. This may be due to the fact that the activity of anthranilate synthase is dependent on the formation of an intact aggregate between the trp2 and trp3 gene products (23) .
An increase in the specific activity of four of the five tryptophan enzymes can be elicited by growth under conditions where the availability of tryptophan becomes growth limiting, as in the presence of analogs or in bradytrophic mutants with a leaky mutation in one of the enzymes of the pathway. It has been shown (P. Niederberger, Ph.D. thesis, Eidgenossische Technische Hochschule, Zurich, Switzerland, 1977) that this derepression is not a specific response of the cell to tryptophan limitation, since derepression of the tryptophan enzymes also occurs upon limitation of unrelated amino acids such as leucine, histidine, and arginine. Similarly, tryptophan limitation causes derepression of histidine and arginine as well as tryptophan enzymes (22) . This general control of amino acid biosynthesis has been reported by several laboratories for both N. crassa (1, 2) and S. cerevisiae (4, 22, 28) and affects at least the basic, the aromatic, and the branched-chain amino acid pathways.
Capacity of the pathway. Anthranilate phosphoribosyltransferase, the second enzyme of the pathway, was synthesized in the smallest excess of all tryptophan enzymes and thus limited the maximal capacity of the pathway under conditions where feedback inhibition of anthranilate synthase was eliminated. While a 50% reduction of the gene dose for the enzyme did not influence growth and enzyme activities, a further reduction caused the enzyme to become limiting and led to reduced growth rate and derepression of the other enzymes of the pathway. From the rates of anthranilate accumulation in the strains of the trp4 gene dosage series under the influence of indole acrylic acid (Table  6 ), one can calculate that the anthranilate phosphoribosyltransferase activity in a strain with an intact trp4 gene dose represents about 65% of the uninhibited activity of anthranilate synthase. This number is consistent with the ratio of the activities of the two enzymes determined in vitro. From the uninhibited in vivo activity of anthranilate synthase, 1.5 nmol/mg of protein per min in a non-derepressed strain, it follows that the basic capacity of the pathway is about 1 nmol/mg of protein per min, about a threefold excess over the value of 0.31 nmol/mg of protein per min needed to maintain the growth rate of the wild-type strain i minimal MV medium. This agrees with the fact that tetraploid cells need less than 50% but more than 25% of the anthranilate phosphoribosyltransferase activity for normal growth.
Although derepression of the tryptophan enzymes led to a further increase in the capacity of the pathway, the basic capacity of the pathway seemed to be sufficient to support growth under all conditions. In particular, growth in the presence of all amino acids except tryptophan did not result in tryptophan limitation or derepression despite a 40% increase in growth rate compared to unsupplemented minimal MV medium. Because of the large reserve capacity of the nonderepressed pathway, it was virtually impossible to cause tryptophan limitation of the wild-type strain without the use of analogs or the introduction of mutations that reduce the flux through the pathway. Thus, tryptophan limitation is unlikely to be encountered by wild-type cells under natural conditions. Possibly, derepression of the tryptophan enzymes is only one aspect of a general response of the cell to amino acid limitation.
